来自同基因转移性和非转移性膀胱癌细胞的分级分离膜和管腔外泌体蛋白的定量蛋白质组学揭示了上皮-间质转化(EMT)因子的差异表达。

Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.

作者信息

Jeppesen Dennis Kjølhede, Nawrocki Arkadiusz, Jensen Steffen Grann, Thorsen Kasper, Whitehead Bradley, Howard Kenneth A, Dyrskjøt Lars, Ørntoft Torben Falck, Larsen Martin R, Ostenfeld Marie Stampe

机构信息

Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.

Abstract

Cancer cells secrete soluble factors and various extracellular vesicles, including exosomes, into their tissue microenvironment. The secretion of exosomes is speculated to facilitate local invasion and metastatic spread. Here, we used an in vivo metastasis model of human bladder carcinoma cell line T24 without metastatic capacity and its two isogenic derivate cell lines SLT4 and FL3, which form metastases in the lungs and liver of mice, respectively. Cultivation in CLAD1000 bioreactors rather than conventional culture flasks resulted in a 13- to 16-fold increased exosome yield and facilitated quantitative proteomics of fractionated exosomes. Exosomes from T24, SLT4, and FL3 cells were partitioned into membrane and luminal fractions and changes in protein abundance related to the gain of metastatic capacity were identified by quantitative iTRAQ proteomics. We identified several proteins linked to epithelial-mesenchymal transition, including increased abundance of vimentin and hepatoma-derived growth factor in the membrane, and casein kinase II α and annexin A2 in the lumen of exosomes, respectively, from metastatic cells. The change in exosome protein abundance correlated little, although significant for FL3 versus T24, with changes in cellular mRNA expression. Our proteomic approach may help identification of proteins in the membrane and lumen of exosomes potentially involved in the metastatic process.

摘要

癌细胞会向其组织微环境中分泌可溶性因子以及包括外泌体在内的各种细胞外囊泡。据推测,外泌体的分泌有助于局部侵袭和转移扩散。在此,我们使用了无转移能力的人膀胱癌细胞系T24及其两个同基因衍生细胞系SLT4和FL3的体内转移模型,这两个衍生细胞系分别在小鼠的肺和肝中形成转移灶。在CLAD1000生物反应器中培养而非在传统培养瓶中培养,使外泌体产量提高了13至16倍,并有助于对外泌体进行分级定量蛋白质组学分析。将来自T24、SLT4和FL3细胞的外泌体分离为膜组分和腔组分,并通过定量iTRAQ蛋白质组学鉴定与转移能力获得相关的蛋白质丰度变化。我们鉴定出了几种与上皮-间质转化相关的蛋白质,包括转移细胞来源的外泌体膜中波形蛋白和肝癌衍生生长因子丰度增加,以及腔中外泌体酪蛋白激酶IIα和膜联蛋白A2丰度增加。外泌体蛋白质丰度的变化与细胞mRNA表达的变化相关性很小,尽管FL3与T24相比有显著相关性。我们的蛋白质组学方法可能有助于鉴定外泌体膜和腔中潜在参与转移过程的蛋白质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索